Similar Stories 🔰

US President Trump declared that India and other US allies would soon substantially decrease their tariffs. This announcement follows his decision to

Jefferies pointed out that India currently imposes up to 10% import duties on US drugs, with some having lower duties or exemptions. If the US enforces reciprocal tariffs, it would be, at best, 10% on imported Indian medicines to the US.

The White House has criticised India's high tariffs on American agricultural products, with Press Secretary Karoline Leavitt calling them "virtually impossible" for US exporters to overcome. As President Trump prepares to roll out reciprocal tariffs on 2 April, the move signals a sharp escalation in trade tensions. While India has offered concessions on select farm imports, it remains protective of its agricultural sector, citing food security and livelihoods. The battle over tariffs is more than just a trade dispute--its a fight over economic priorities.

Arvind Sanger of Geosphere Capital Management shares his skepticism about the clarity of President Trump's impending tariff announcement. He believes negotiations and adjustments will follow. Sanger does not see tariffs as a definitive solution. He highlights that India is acting intelligently by not retaliating immediately. Investors are advised to remain cautious and consider buying opportunities in unaffected sectors.

The United States Trade Representative (USTR) has highlighted several trade and regulatory challenges in Monday's National Trade Estimate (NTE) Report, raising concerns over India's tariffs, non-tariff barriers, intellectual property policies, digital trade, and transparency.

US President Donald Trump is preparing to impose new tariffs, arguing that reciprocal trade measures are necessary to address long-standing trade imbalances. His approach has unsettled global markets and raised fears of a trade war, with key economies like China, Canada, and the EU bracing for impact. While Trump insists his policies will benefit the US, critics warn of economic pain and a possible global slowdown. Meanwhile, allies are seeking ways to mitigate the fallout.

Asian nations are grappling with crucial decisions as President Trump's reciprocal tariffs challenge their export-based economies. The new levies will impact key regional players, potentially trimming economic growth significantly. Leaders aim to diversify trade and strengthen domestic markets to mitigate the effects while avoiding direct retaliation against the US.

The tariffs could damage the global trading system and empower China, while increasing costs for American consumers and businesses.

The financial markets are questioning the belief in US exceptionalism due to tariff threats and uncertainties, shifting their view towards vulnerabilities similar to other economies. This has led to a downward trend in the USD. The global economy grew by 3.3% in 2024, but US trade policies and other factors are creating a volatile macroeconomic environment.

Indias pharmaceutical industry is facing potential tariffs imposed by President Trump, which could significantly impact exports, particularly to the US. High export dependence and questionable quality standards underscore the need for reform and improved regulation to maintain the industrys reputation and market position.